Cipla’s Pitch For Low-Cost Pharmaceuticals

Feb 04 2014

January 29: Cipla Chairman Y.K. Hamied shares his vision for the company and its journey over the years as a leader in pharma innovation. He discusses the company’s role in making medicines accessible and changing India’s reputation as a provider of low-cost alternatives to drugs. He discusses the creation of the anti-HIV Triomune drug and arriving at the game-changing recipe of success.